Cancer Family
Rare Neoplasm
CI-CAN-00000048Explore in graph →
Non-malignant115 active trials3 approved drugs7 evidence items
- NCIt
- C7201
Loading cancer entity…
Cancer Family
CI-CAN-00000048Explore in graph →
Clinical trials
360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03874455 | Tazemetostat Expanded Access Program for Adults With Solid Tumors | no longer available | — | — | Epizyme, Inc.INDUSTRY | 0 | Jul 2, 2026 | clinicaltrials |
| NCT05219266 | Managed Access Programs for PKC412, Midostaurin | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 0 | Jun 28, 2024 | clinicaltrials |
Showing 1–2 of 2 studies
Data updated 22 days agoSource updated Jul 2, 2026source: clinicaltrials